Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Myllylä V. V., Sotaniemi K. A., Vuorinen J. A., Heinonen E. H. Selegiline as initial treatment in de novo parkinsonian patients. Neurology. 1992 Feb;42(2):339–343. doi: 10.1212/wnl.42.2.339. [DOI] [PubMed] [Google Scholar]
- Tetrud J. W., Langston J. W. The effect of deprenyl (selegiline) on the natural history of Parkinson's disease. Science. 1989 Aug 4;245(4917):519–522. doi: 10.1126/science.2502843. [DOI] [PubMed] [Google Scholar]